Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity
Bibliographic Data
| ID | 14746016 |
|---|---|
| Authors | Ziyue Zhu (0009-0004-3239-5681, Nanjing University of Chinese Medicine), Mei Yu (0000-0002-0283-9649, Nanjing University of Chinese Medicine), Mengfan Xu (0000-0002-8645-2440, Nanjing University of Chinese Medicine), Xin Ji (0009-0003-3355-2119, Yangzhou University), Xicui Zong (Nanjing University of Chinese Medicine), Zhenwen Zhang (0000-0001-8443-8779, Yangzhou University, corresponding author), Wenbin Shang (0000-0002-0317-5928, Nanjing University of Chinese Medicine, corresponding author), Li Zhang (0000-0002-4441-5131, Nanjing University of Chinese Medicine, corresponding author), Penghua Fang (0000-0002-8915-0616, Nanjing University of Chinese Medicine, corresponding author) |
| Year | 2024 |
| Volume | 332 |
| Pages | 118355 |
| Publication date | 2024-10-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2024.118355 |
| PMID | 38762213 |
| OpenAlex | W4396954653 |
| Language | EN |
| Citations received | 2 |
| References cited | 53 |
Adipose tissue · Adipose tissue macrophages · Baicalin · Biology · In vitro · Inflammation · Insulin · Insulin resistance · Macrophage · Obesity · Adipokines, Inflammation, and Metabolic Diseases · Adipose Tissue and Metabolism · Atherosclerosis and Cardiovascular Diseases · Chemistry · Medicine · Biochemistry · Endocrinology · Internal Medicine
Puerarin from Pueraria montana var. lobata (Willd.) alleviates hepatic steatosis and inflammation in MAFLD through suppressing STING-IRF3/NF-κB signaling in macrophages
Clinacanthus nutans (Burm. f.) Lindau ameliorates type 2 diabetes mellitus by suppressing chemokine-mediated inflammation and apoptosis in pancreatic β-cells
| Unique citing works | 2 |
|---|---|
| Citations per year | 2 |
| Citation span | 2026 - 2026 (1) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |